Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM
Dec 18, 2025 07:30AM
Dec 18, 2025 07:30AM
Dec 10, 2025 07:30AM
Dec 10, 2025 07:30AM
Dec 1, 2025 07:30AM ProMIS shares new data on plasma biomarker for alzheimer's trials
Dec 1, 2025 07:30AM
Nov 24, 2025 08:00AM
Nov 24, 2025 08:00AM
Nov 12, 2025 07:09AM
Nov 12, 2025 07:00AM
Nov 12, 2025 07:00AM
Oct 22, 2025 07:31AM ProMIS Neurosciences (PMN) Appoints Dr. Slanix Paul Alex to Board
Oct 22, 2025 07:30AM
Sep 3, 2025 07:00AM
Sep 3, 2025 07:00AM
Aug 13, 2025 06:51PM
Aug 13, 2025 07:00AM
Aug 13, 2025 07:00AM
Jul 29, 2025 08:00AM ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
Jul 29, 2025 08:00AM
Jul 28, 2025 07:01AM
Jul 28, 2025 07:00AM
Jul 22, 2025 08:53AM
Jul 22, 2025 07:01AM
Jul 22, 2025 07:00AM
Jul 21, 2025 08:04AM ProMIS Neurosciences receives FDA fast track status for Alzheimer's drug
Jul 21, 2025 08:00AM
May 13, 2025 06:33AM
May 12, 2025 07:30AM
Mar 31, 2025 07:00AM
Mar 24, 2025 07:01AM
Mar 24, 2025 07:00AM
Mar 13, 2025 07:00AM ProMIS Neurosciences (PMN) Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases
Mar 13, 2025 07:00AM
Feb 25, 2025 07:01AM
Feb 25, 2025 07:00AM
Jan 13, 2025 10:40AM
Jan 13, 2025 10:30AM
Jan 10, 2025 07:03AM
Jan 10, 2025 07:00AM ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
Nov 14, 2024 05:20PM
Nov 14, 2024 09:15AM
Oct 30, 2024 08:01AM
Oct 30, 2024 08:00AM
Sep 12, 2024 07:03AM
Sep 12, 2024 07:00AM
Sep 12, 2024 07:00AM ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive
Aug 8, 2024 07:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All